• Pharma
  • March 24, 2025
  • 211 views
SMS Pharma gains after Hyderabad facility completes USFDA inspection

SMS Pharmaceuticals rose 1.79% to Rs 221.80 after company announced that it has successfully completed a US Food and Drug Administration (USFDA) inspection at its API manufacturing facility located in…

  • Pharma
  • October 14, 2023
  • 266 views
CDSCO approves India’s first CAR-T cell therapy against certain blood cancers

ImmunoACT is an IIT Bombay incubated company-backed by drug maker Laurus Labs on Friday said it has received approval from Indian drug regulator the Central Drugs Standard Control Organization (CDSCO) for its…